![Eric Burak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Burak
Directeur Technique/Scientifique/R&D chez
FUSN PHAR
Profil
Eric Burak is currently Chief Technology Officer at Fusion Pharmaceuticals, Inc. since 2021, with employment at the company starting in 2017.
Former positions include Director-Drug Metabolism & Pharmacokinetics at Guilford Pharmaceuticals, Inc., Vice President-Advanced Preclinical Development at Melinta Subsidiary Corp., Vice President-Development at Theracos, Inc. from 2011 to 2012, and Chief Scientific Officer at Centre For Probe Development & Commercialization from 2012 to 2017.
Education includes undergraduate studies at Drexel University and a doctorate from Temple University (Pennsylvania).
Postes actifs de Eric Burak
| Sociétés | Poste | Début |
|---|---|---|
| FUSN PHAR | Directeur Technique/Scientifique/R&D | 01/02/2017 |
Anciens postes connus de Eric Burak
| Sociétés | Poste | Fin |
|---|---|---|
Centre For Probe Development & Commercialization
 Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Directeur Technique/Scientifique/R&D | 01/02/2017 |
Theracos, Inc.
 Theracos, Inc. BiotechnologyHealth Technology Develops novel therapeutics for diseases | Corporate Officer/Principal | 01/10/2012 |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Corporate Officer/Principal | - |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Corporate Officer/Principal | - |
Formation de Eric Burak
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Health Technology |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
Theracos, Inc.
Theracos, Inc. BiotechnologyHealth Technology Develops novel therapeutics for diseases | Health Technology |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Health Technology |
